Two isoforms of tissue transglutaminase mediate opposing cellular fates

被引:78
作者
Antonyak, Marc A. [1 ]
Jansen, Jaclyn M. [1 ]
Miller, Allison M. [1 ]
Ly, Thi K. [1 ]
Endo, Makoto [1 ]
Cerione, Richard A. [1 ]
机构
[1] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA
关键词
aggregation; cell death; transamidation;
D O I
10.1073/pnas.0604844103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Opposing cellular responses are typically regulated by distinct sets of genes. However, tissue transglutaminase (TGase) provides an interesting example of a single gene product that has been implicated both in affording protection against cellular insults as well as in promoting cell death. Here, we shed some light on how these conflicting activities might be manifested by demonstrating that alternative transcripts of TGase differentially affect cell viability. We show that although the full-length TGase protein affords strong protection against cell death signals, a shorter version of TGase that is truncated at the 3' end, and thus called TGase-short (TGase-S), is cytotoxic. The apoptotic activity of TGase-S is not dependent on its transamidation activity because the mutation of a cysteine residue that is essential for catalyzing this reaction does not compromise the ability of TGase-S to induce cell death. Intriguingly, TGase-S undergoes inappropriate oligomer formation in cells before cell death, suggesting a novel mechanism for the apoptotic effects of this protein.
引用
收藏
页码:18609 / 18614
页数:6
相关论文
共 31 条
[11]  
FRAIJ BM, 1992, J BIOL CHEM, V267, P22616
[12]   Transglutaminases: Nature's biological glues [J].
Griffin, M ;
Casadio, R ;
Bergamini, CM .
BIOCHEMICAL JOURNAL, 2002, 368 :377-396
[13]   Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells [J].
Herman, J. F. ;
Mangala, L. S. ;
Mehta, K. .
ONCOGENE, 2006, 25 (21) :3049-3058
[14]   Transglutaminase activity is increased in Alzheimer's disease brain [J].
Johnson, GVW ;
Cox, TM ;
Lockhart, JP ;
Zinnerman, MD ;
Miller, ML ;
Powers, RE .
BRAIN RESEARCH, 1997, 751 (02) :323-329
[15]   Tissue transglutaminase-induced aggregation of α-synuclein:: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies [J].
Junn, E ;
Ronchetti, RD ;
Quezado, MM ;
Kim, SY ;
Mouradian, MM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) :2047-2052
[16]   Transglutaminase action imitates Huntington's disease: Selective polymerization of huntingtin containing expanded polyglutamine [J].
Kahlem, P ;
Green, H ;
Djian, P .
MOLECULAR CELL, 1998, 1 (04) :595-601
[17]   Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei [J].
Karpuj, MV ;
Garren, H ;
Slunt, H ;
Price, DL ;
Gusella, J ;
Becher, MW ;
Steinman, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (13) :7388-7393
[18]   Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine [J].
Karpuj, MV ;
Becher, MW ;
Springer, JE ;
Chabas, D ;
Youssef, S ;
Pedotti, R ;
Mitchell, D ;
Steinman, L .
NATURE MEDICINE, 2002, 8 (02) :143-149
[19]   Differential expression of multiple transglutaminases in human brain - Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease [J].
Kim, SY ;
Grant, P ;
Lee, JH ;
Pant, HC ;
Steinert, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (43) :30715-30721
[20]  
Lesort M, 1999, J NEUROCHEM, V73, P2018